載入...
Timing and Targeting of Treatment in Left Ventricular Hypertrophy
In most clinical cases, left ventricular hypertrophy (LVH) occurs over time from persistent cardiac stress. At the molecular level, this results in both transient and long-term changes to metabolic, sarcomeric, ion handling, and stress signaling pathways. Although this is initially an adaptive chang...
Na minha lista:
| 發表在: | Methodist Debakey Cardiovasc J |
|---|---|
| Main Authors: | , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
The Methodist Hospital Houston, Texas
2017
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5385802/ https://ncbi.nlm.nih.gov/pubmed/28413576 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.14797/mdcj-13-1-9 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|